GlassScriptPhysician profile
George G Thomas
NPI 1972526614
$933.63
in general payments reported to CMS, 2019-2025
16 companies · $385 in 2025
The $385 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $68.40 · 2021: $212 · 2022: $68.78 · 2023: $58.06 · 2024: $36.48 · 2025: $385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $479.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $311.50 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $203.37 | 2025 | Hammr Curved G7 Impactor, G7, Z1 Hip System |
| Ossur Americas, INC. | $71.39 | 2025 | |
| Gilead Sciences, INC. | $66.57 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.33 | 2021 | |
| Exact Sciences Corporation | $32.60 | 2024-2025 | Cologuard Collection Kit |
| Abbvie INC. | $28.38 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $26.26 | 2022-2023 | Breztri |
| Antares Pharma, INC. | $23.53 | 2023 | Xyosted, Tlando, Nocdurna |
| Vertex Pharmaceuticals Incorporated | $23.26 | 2025 | |
| Abbott Laboratories | $22.71 | 2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $21.30 | 2024 | Arexvy, Shingrix, Bexsero |
| Xeris Pharmaceuticals, INC. | $21.10 | 2023 | Keveyis |
| Takeda Pharmaceuticals U.S.A., INC. | $15.68 | 2019 | |
| Sanofi Pasteur INC. | $15.67 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $14.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.